By technology, the LDCT segment will account maximum share in lung cancer screening market during 2022-2030. The lung cancer screening industry majorly.
North America dominates the global occupational health market, which was valued at $1,997.85 million in 2022 and is projected to reach $2,529.51 million by.
North America was the largest decapping system market, valued at $137.19 million in 2022; it is expected to grow at a CAGR of 5.1% during 2022-2028. The key players in the decapping system industry includes Hamilton Co, LVL technologies GmbH & Co KG, Micronic Holding BV, Sarstedt AG and Co KG, Thermo Fisher Scientific Inc, Azenta Inc, Dominique Dutscher SAS, Cole-Parmer Instrument Co LLC, Agilent Technologies Inc, and AltemisLab Ltd.Pune, India, July 04, 2023 (GLOBE NEWSWIRE) According to Rec
Decapping System Market To Reach $383 25Mn By 2028 At 5 1% Cagr With Automated Segment Driving Growth During 20222028 | The Insight Partners menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Asia Pacific held the largest share for smart pills market; which is projected to reach $1,156.22 million by 2028 and was valued at $488.75 million in.